Cartiva: A Review of the Best Evidence
- PMID: 39068023
- DOI: 10.1016/j.fcl.2023.11.004
Cartiva: A Review of the Best Evidence
Abstract
The Cartiva implant is a synthetic polyvinyl alcohol hydrogel cartilage substitute that is used as a treatment of first metatarsophalangeal joint arthritis. The implant was designed to relieve the pain associated with hallux rigidus while preserving or restoring range of motion. A summary of outcomes, reasons for these outcomes, and technique pearls will be reviewed here. Seminal articles and current evidence are all included in this article. The aim is for the surgeon to understand all the literature, allowing the surgeon to counsel their patients appropriately, optimize patient selection and to deal with complications.
Keywords: Cartiva; Hemiarthropasty; Hydrogel; Polyvinyl.
Published by Elsevier Inc.
Conflict of interest statement
Disclosure The authors certify that neither (s)he nor any members of his or her immediate family have any commercial associations (such as consultancies, stock ownership, equity interest, patent/licensing arrangements, and so forth) that might pose a conflict of interest in connection with the submitted article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
